rolitetracycline ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antibiotics, protein-synthesis inhibitors, tetracycline derivatives 2399 751-97-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • synterin
  • rolitetracycline
A pyrrolidinylmethyl TETRACYCLINE.
  • Molecular weight: 527.57
  • Formula: C27H33N3O8
  • CLOGP: 0.05
  • LIPINSKI: 3
  • HAC: 11
  • HDO: 6
  • TPSA: 170.87
  • ALOGS: -2.47
  • ROTB: 4

Drug dosage:

DoseUnitRoute
0.35 g P

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 3 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 1250 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 55 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 11.05 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
Vd (Volume of distribution) 0.54 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 0.97 mL/min/kg Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma) 0.50 % Lombardo F, Berellini G, Obach RS
t_half (Half-life) 8.80 hours Lombardo F, Berellini G, Obach RS

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC J01AA09 ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
TETRACYCLINES
Tetracyclines
MeSH PA D000900 Anti-Bacterial Agents
MeSH PA D000890 Anti-Infective Agents
CHEBI has role CHEBI:35820 antiprotozoal drugs
CHEBI has role CHEBI:36047 antibacterial drugs
CHEBI has role CHEBI:48001 protein synthesis inhibitors
CHEBI has role CHEBI:50266 Prodrugs

Drug Use | Suggest Off label Use Form| |View source of the data|

None




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 3.72 acidic
pKa2 7.59 acidic
pKa3 9.76 acidic
pKa4 11.9 acidic
pKa5 13.05 acidic
pKa6 13.72 acidic
pKa7 9.07 Basic
pKa8 8.21 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Insulin-degrading enzyme Enzyme IC50 4 CHEMBL
DNA repair protein RAD52 homolog Nuclear other IC50 4.54 CHEMBL
Integrase Enzyme IC50 4.55 CHEMBL
Integrase Enzyme IC50 4.55 CHEMBL

External reference:

IDSource
N0000167345 NUI
D02282 KEGG_DRUG
C0035823 UMLSCUI
CHEBI:63334 CHEBI
CHEMBL1237046 ChEMBL_ID
D012382 MESH_DESCRIPTOR_UI
DB01301 DRUGBANK_ID
12760 IUPHAR_LIGAND_ID
1041 INN_ID
GH9IW85221 UNII
54682938 PUBCHEM_CID
9462 RXNORM
002746 NDDF
96076003 SNOMEDCT_US

Pharmaceutical products:

None